EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report

Yuqiang Zhou, Zhiliang Zhang, Shasha Liu, Jiang Nan, Zhuoli Zhang, Zixian Chen

Frontiers in Cardiovascular Medicine · 03.06.2026 · 13

DOI: 10.3389/fcvm.2026.1749534 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.06.2026. Verfasst von Yuqiang Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) are pivotal in treating advanced malignancies, including hepatocellular carcinoma (HCC). However, they can trigger immune-related adverse events (irAEs), among which myocarditis is one of the most life-threatening. Herein, we report the case of a 56-year-old man with HCC who developed myocarditis after receiving two cycles of the PD-1 inhibitor sintilimab. The diagnosis was established via cardiac magnetic resonance (CMR) and confirmed by endomyocardial biopsy (EMB). Following treatment with high-dose corticosteroids and supportive therapy, the patient's condition exhibited significant improvement.

Schlagwörter

Stichwörter der Autor:innen

cardiac magnetic resonanceendomyocardial biopsyhepatocellular carcinomaimmune checkpoint inhibitorsimmune-related adverse eventsmyocarditis

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
  • Department of Pathology, The First Hospital of Lanzhou University, Lanzhou, China.
  • Department of Radiology, The First Hospital of Lanzhou University, Lanzhou, China.
  • Departments of Radiological Sciences, University of California, Irvine, CA, United States.

Zitieren

APA

Zhou, Y., Zhang, Z., Liu, S., Nan, J., Zhang, Z., & Chen, Z. (2026). Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1749534

Vancouver

Zhou Y, Zhang Z, Liu S, Nan J, Zhang Z, Chen Z. Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1749534

BibTeX
@article{Zhou2026,
  author = {Zhou, Yuqiang and Zhang, Zhiliang and Liu, Shasha and Nan, Jiang and Zhang, Zhuoli and Chen, Zixian},
  title = {Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1749534}
}
Kostenlos starten →